Home / Health / Mushroom Therapy Reverses Alzheimer's Decline?
Mushroom Therapy Reverses Alzheimer's Decline?
5 Jun
Summary
- Experimental psilocybin dose showed remarkable recovery in Alzheimer's patient.
- Patient regained speech, continence, and cognitive abilities temporarily.
- Study suggests lost function may be inaccessible, not permanently gone.
In a remarkable case study, an 80-year-old woman with advanced Alzheimer's disease demonstrated significant improvements after receiving a single dose of psilocybin, the active compound in magic mushrooms. Previously experiencing severe cognitive decline, including incontinence and communication loss, the patient showed a notable recovery in her speech, continence, and social interaction within days of the experimental treatment.
The patient began speaking in full sentences, recalling life events, and regaining autonomy in daily tasks like dressing and maintaining continence. A subsequent dose led to further enhancements in verbal expression and mobility. However, researchers emphasized that these improvements were temporary and did not reverse the underlying neurodegeneration.
This study, published in Frontiers in Neuroscience, suggests that functions believed to be irrevocably lost in late-stage dementia may merely be inaccessible. Psilocybin's ability to facilitate new brain connections and activate serotonin receptors offers potential for temporary recovery of these lost functions. The authors acknowledge the single-patient model as a limitation, warranting further investigation into the therapeutic potential of psychedelics for Alzheimer's intervention.
